Sign up for our free daily newsletter
Get the latest news and some fun stuff
in your inbox every day
Stryker is a global leader in medical technologies with innovative products and services in surgical equipment, neurotechnology, and orthopaedics. They have been a Vestact-recommended stock since January 2014.
It's my turn to write about their recent quarterly results, which were very good, but I had promised an "images only" week, so I will confine myself to one line, and then post the image below.
Stryker has steadily increased its cash dividend every year since the last century - they even did so during Covid in 2020 and 2021, when elective surgeries fell off sharply.
